1. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma
   Guangyi Jiang et al, 2020, Aging CrossRef
2. Elevated NLR May Be a Feature of Pediatric Brain Cancer Patients
   Michal Yalon et al, 2019, Frontiers in Oncology CrossRef
3. Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis
   Maria Buñuales et al, 2021, International Journal of Molecular Sciences CrossRef
4. Siah2 control of T-regulatory cells limits anti-tumor immunity
   Marzia Scortegagna et al, 2020, Nature Communications CrossRef
5. TIGIT Induces (CD3+) T Cell Dysfunction in Colorectal Cancer by Inhibiting Glucose Metabolism
   Qi Shao et al, 2021, Frontiers in Immunology CrossRef
6. Engineered DBCO+PD-1 Nanovesicles Carrying 1-MT for Cancer-Targeted Immunotherapy
   Xichao Xu et al, 2022, ACS Biomaterials Science & Engineering CrossRef
7. Immunomodulatory Organic and Polymer Nanomedicine in Cancer Therapy
   Anubhab Mukherjee et al, 2021, Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy CrossRef
8. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
   Jumpei Kondo et al, 2019, Cells CrossRef
9. Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
   Lilv Fan et al, 2021, Cancers CrossRef
10. Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer Immunotherapy
    Bo Liu et al, 2021, Nano Letters CrossRef